Designer immune-cell therapy could shrink deadly brain tumors, early trials show - Livescience.com
livescience.comSubmitted by livescience8748 in news
Two early clinical trials that together included nine patients suggest that a treatment called CAR-T therapy could treat glioblastoma, but its long-term effects are unknown.